Expression Table for this CRE
| CNhs13533 | CD14+ monocytes - treated with lipopolysaccharide, donor2 | 38.8 |
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 3.1 |
| CNhs13843 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 2.6 |
| CNhs14444 | COBL-a rinderpest(-C) infection, 48hr, biol_rep1 | 2.3 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 2.2 |
| CNhs13332 | Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3) | 2.0 |
| CNhs14432 | COBL-a rinderpest infection, 48hr, biol_rep2 | 1.7 |
| CNhs11986 | Smooth Muscle Cells - Carotid, donor2 | 1.6 |
| CNhs13838 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1 | 1.5 |
| CNhs13049 | acute myeloid leukemia (FAB M7) cell line:M-MOK | 1.3 |
| CNhs11992 | Synoviocyte, donor2 | 1.2 |
| SRX6586336 | CNhi10317_MCF-7_Rosuvastatin-30 uM-6h_rep1 | 1.0 |
| CNhs13725 | HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3 | 1.0 |
| CNhs12698 | K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 0.9 |
| CNhs13345 | Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 0.8 |
| CNhs13379 | Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 0.8 |
| CNhs13499 | Hep-2 cells treated with Streptococci strain JRS4, biol_rep3 | 0.8 |
| SRX9760367 | skeletal muscle_1_h_after_exercise (Individual 4) | 0.8 |
| CNhs11991 | Smooth Muscle Cells - Umbilical Artery, donor2 | 0.7 |
| SRX9760354 | skeletal muscle_6_h_after_exercise (Individual 1) | 0.7 |
| CNhs14499 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 0.6 |
| CNhs12824 | H9 Embryonic Stem cells, biol_rep2 (H9ES-2) | 0.6 |
| SRX9760355 | skeletal muscle_prior_exercise (Individual 2) | 0.5 |
| CNhs11858 | mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162 | 0.5 |
| CNhs11869 | somatostatinoma cell line:QGP-1 | 0.5 |
| CNhs12925 | Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 0.5 |
| CNhs13640 | Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h) | 0.5 |
| SRX6586367 | CNhi10369_MCF-7_siRNA-negative control-48h_rep3 | 0.5 |
| CNhs11844 | acantholytic squamous carcinoma cell line:HCC1806 | 0.4 |
| CNhs12228 | pineal gland, adult, donor10252 | 0.4 |
| CNhs14060 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 0.4 |
| SRX6586351 | CNhi10319_MCF-7_Rosuvastatin-30 uM-48h_rep3 | 0.4 |
| CNhs12948 | H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 0.4 |
| CNhs12463 | K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1 | 0.4 |
| CNhs13965 | H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1 | 0.4 |
| CNhs13578 | Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36) | 0.4 |
| CNhs13495 | CD14+ monocytes - treated with B-glucan, donor3 | 0.4 |
| SRX6586362 | CNhi10331_MCF-7_siRNA (HSS179267) treatment-48h_rep2 | 0.3 |
| CNhs11777 | rectum, fetal, donor1 | 0.3 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 0.3 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 0.3 |
| CNhs13362 | Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14) | 0.3 |
| SRX6586339 | CNhi10318_MCF-7_Atrovastatin-30 uM-48h_rep1 | 0.3 |
| SRX6586338 | CNhi10317_MCF-7_Rosuvastatin-30 uM-6h_rep3 | 0.3 |
| CNhs13598 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2 | 0.3 |
| CNhs13367 | Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 0.2 |
| CNhs14576 | Myoblast differentiation to myotubes, day12, control donor2 | 0.2 |
| CNhs11988 | Smooth Muscle Cells - Internal Thoracic Artery, donor2 | 0.2 |
| SRX6586352 | CNhi10330_MCF-7_siRNA (HSS104864) treatment-48h_rep1 | 0.2 |
| CNhs12798 | K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3 | 0.2 |